Pedro R. Löwenstein

18.1k total citations
304 papers, 11.1k citations indexed

About

Pedro R. Löwenstein is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Pedro R. Löwenstein has authored 304 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Molecular Biology, 118 papers in Genetics and 89 papers in Immunology. Recurrent topics in Pedro R. Löwenstein's work include Virus-based gene therapy research (111 papers), RNA Interference and Gene Delivery (63 papers) and Glioma Diagnosis and Treatment (55 papers). Pedro R. Löwenstein is often cited by papers focused on Virus-based gene therapy research (111 papers), RNA Interference and Gene Delivery (63 papers) and Glioma Diagnosis and Treatment (55 papers). Pedro R. Löwenstein collaborates with scholars based in United States, United Kingdom and Argentina. Pedro R. Löwenstein's co-authors include María G. Castro, Kurt M. Kroeger, James F. Curtin, Esteban Domingo, Joseph T. Coyle, Gwendalyn D. King, Chunyan Liu, Marianela Candolfi, Mariana Puntel and Saleta Sierra and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Pedro R. Löwenstein

295 papers receiving 10.9k citations

Peers

Pedro R. Löwenstein
María G. Castro United States
Keiya Ozawa Japan
Osamu Ohara Japan
Michael Stadler Germany
Raju Kucherlapati United States
Peter Forsyth United States
Luigi Frati Italy
Seng H. Cheng United States
Charles D. Stiles United States
Dieter E. Jenne Germany
María G. Castro United States
Pedro R. Löwenstein
Citations per year, relative to Pedro R. Löwenstein Pedro R. Löwenstein (= 1×) peers María G. Castro

Countries citing papers authored by Pedro R. Löwenstein

Since Specialization
Citations

This map shows the geographic impact of Pedro R. Löwenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro R. Löwenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro R. Löwenstein more than expected).

Fields of papers citing papers by Pedro R. Löwenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro R. Löwenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro R. Löwenstein. The network helps show where Pedro R. Löwenstein may publish in the future.

Co-authorship network of co-authors of Pedro R. Löwenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro R. Löwenstein. A scholar is included among the top collaborators of Pedro R. Löwenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro R. Löwenstein. Pedro R. Löwenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madsen, Peter J., Pedro R. Löwenstein, Maria G. Castro, et al.. (2024). The transformative potential of mRNA vaccines for glioblastoma and human cancer: technological advances and translation to clinical trials. Frontiers in Oncology. 14. 1454370–1454370. 6 indexed citations
2.
Condro, Michael, Riki Kawaguchi, Yue Qin, et al.. (2024). Valproic acid targets IDH1 mutants through alteration of lipid metabolism. SHILAP Revista de lepidopterología. 2(1). 20–20.
3.
Varela, María L., Andrea Comba, Syed Mohd Faisal, et al.. (2022). Gene Therapy for High Grade Glioma: The Clinical Experience. Expert Opinion on Biological Therapy. 23(2). 145–161. 16 indexed citations
4.
Comba, Andrea, Syed Mohd Faisal, Patrick Dunn, et al.. (2022). Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression. Nature Communications. 13(1). 3606–3606. 56 indexed citations
5.
Comba, Andrea, Patrick Dunn, Padma Kadiyala, et al.. (2020). Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responses. Neuro-Oncology. 22(6). 806–818. 38 indexed citations
6.
Mendez, Flor, Padma Kadiyala, Felipe J. Núñez, et al.. (2020). Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma. Clinical Cancer Research. 26(15). 4080–4092. 19 indexed citations
7.
Alghamri, Mahmoud S., Ali Dabaja, Ayman Taher, et al.. (2020). Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1. Neuro-Oncology Advances. 2(1). vdaa042–vdaa042. 17 indexed citations
8.
Garcia-Fabiani, María Belén, Andrea Comba, Marianela Candolfi, et al.. (2020). Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development. Expert Opinion on Investigational Drugs. 29(7). 659–684. 17 indexed citations
9.
Scheetz, Lindsay, Padma Kadiyala, Xiaoqi Sun, et al.. (2020). Synthetic High-density Lipoprotein Nanodiscs for Personalized Immunotherapy Against Gliomas. Clinical Cancer Research. 26(16). 4369–4380. 64 indexed citations
10.
Calinescu, Anda‐Alexandra, Viveka Nand Yadav, Padma Kadiyala, et al.. (2016). Survival and Proliferation of Neural Progenitor–Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism. Clinical Cancer Research. 23(5). 1250–1262. 38 indexed citations
11.
Mineharu, Yohei, Neha Kamran, Pedro R. Löwenstein, & María G. Castro. (2014). Blockade of mTOR Signaling via Rapamycin Combined with Immunotherapy Augments Antiglioma Cytotoxic and Memory T-Cell Functions. Molecular Cancer Therapeutics. 13(12). 3024–3036. 38 indexed citations
12.
Candolfi, Marianela, Kader Yagiz, Mariana Puntel, et al.. (2014). Temozolomide Does Not Impair Gene Therapy-Mediated Antitumor Immunity in Syngeneic Brain Tumor Models. Clinical Cancer Research. 20(6). 1555–1565. 28 indexed citations
13.
Baker, Gregory J., Peter Chockley, Viveka Nand Yadav, et al.. (2014). Natural Killer Cells Eradicate Galectin-1–Deficient Glioma in the Absence of Adaptive Immunity. Cancer Research. 74(18). 5079–5090. 61 indexed citations
14.
Mineharu, Yohei, Gwendalyn D. King, Serguei Bannykh, et al.. (2011). Engineering the Brain Tumor Microenvironment Enhances the Efficacy of Dendritic Cell Vaccination: Implications for Clinical Trial Design. Clinical Cancer Research. 17(14). 4705–4718. 30 indexed citations
15.
Castro, María G., Marianela Candolfi, Kurt M. Kroeger, et al.. (2011). Gene Therapy and Targeted Toxins for Glioma. Current Gene Therapy. 11(3). 155–180. 62 indexed citations
16.
Candolfi, Marianela, Kader Yagiz, David Foulad, et al.. (2009). Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity. Clinical Cancer Research. 15(13). 4401–4414. 80 indexed citations
17.
Curtin, James F., Naiyou Liu, Marianela Candolfi, et al.. (2009). HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression. PLoS Medicine. 6(1). e1000010–e1000010. 288 indexed citations
18.
Löwenstein, Pedro R.. (2008). Clinical trials in gene therapy: ethics of informed consent and the future of experimental medicine.. PubMed. 10(5). 428–30. 12 indexed citations
19.
Zirger, Jeffrey M., Carlos Barcia, Chunyan Liu, et al.. (2006). Rapid Upregulation of Interferon-Regulated and Chemokine mRNAs upon Injection of 10 8 International Units, but Not Lower Doses, of Adenoviral Vectors into the Brain. Journal of Virology. 80(11). 5655–5659. 16 indexed citations
20.
Southgate, T. D., Joseph R. Smith-Arica, Christian A. Gerdes, et al.. (2000). Transcriptional Targeting to Anterior Pituitary Lactotrophic Cells Using Recombinant Adenovirus Vectors in Vitro and in Vivo in Normal and Estrogen/Sulpiride-Induced Hyperplasic Anterior Pituitaries*. Endocrinology. 141(9). 3493–3505. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María G. Castro Breakdown of academic impact, for papers by Keiya Ozawa Breakdown of academic impact, for papers by Osamu Ohara Breakdown of academic impact, for papers by Michael Stadler Breakdown of academic impact, for papers by Raju Kucherlapati Breakdown of academic impact, for papers by Peter Forsyth Breakdown of academic impact, for papers by Luigi Frati Breakdown of academic impact, for papers by Seng H. Cheng Breakdown of academic impact, for papers by Charles D. Stiles Breakdown of academic impact, for papers by Dieter E. Jenne
Rankless by CCL
2026